News and blog posts
27
Dec 2021
On December 17, 2021, NHS Digital released HRG4+ Consultation Grouper for 2022/23. This release is used to support the NHS England and Improvement consultation process for the 2022/23 National Tariff Payment System. In general, there are significant changes in base HRG design. A total of 120 new HRGs were created, multiple HRGs were removed, and the grouping logic was updated significantly. This Consultation Grouper will be superseded by the 2022/23 Local Payment Grouper in March 2022, for use from April 01, 2022.
Read more
24
Dec 2021
In November 2021, twelve clinical guidelines, relating to gastrointestinal, ENT, orthopedic, and other disease areas, were released in Russia.
Read more
23
Dec 2021
In November 2021, the National Institute for Health Research (NIHR) in England released three MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned delivery for preterm birth, thoracolumbar fracture, and knee replacement. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.
Read more
22
Dec 2021
The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 20520 of November 22, 2021, Tuscany Regional Healthcare has published assessments of seventeen medical devices of various therapeutic areas, including devices belonging to neurology, as well as gastrointestinal, urology, cardiovascular, orthopedics, peripheral vascular, and other fields of care.
Read more
21
Dec 2021
On December 06, 2021, the President of the Russian Federation signed the Federal Law on a budget of mandatory Health Insurance for 2022 and the planning period of 2023 and 2024. In accordance with the approved budget, the amount of High-end Medical Care outside the basic compulsory medical insurance program for federal clinics will be 109.9 billion RUB which is an increase of 2.7 billion RUB.
Read more
20
Dec 2021
The new version of the classification of procedure codes (CCAM v.68) applicable from 09/12/2021 was published in France. Multiple changes were introduced, including registration of 22 new procedure codes, changes of notes and tariffs for procedure codes, removal of two codes, and other changes. New codes are related to procedures on the gastrointestinal tract, surgical procedures, peripheral vascular procedures, etc.
Read more
17
Dec 2021
The Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) systematically evaluates healthcare technologies and practices from medical, economic, ethical, and social standpoints. The following assessments were initiated in the third quarter of 2021: ultrasound-guided arterial catheters insertion in adults, the basis for national guidelines for heart disease. The final reports will be published on the SBU website upon completion
Read more
16
Dec 2021
On December 2, 2021, the Digital Health Strategy of the National Health System (SNS) was approved by the Interterritorial Council of the National Health System (CISNS) with an endowment of more than €675 million within the Transformation, Recovery, and Resilience Mechanism of the Government of Spain. The Digital Health Strategy is expected to promote the SNS values such as equity, sustainability, and transparency and boost the transformation of the SNS care model in the upcoming years.
Read more
15
Dec 2021
In 2015, the Federal Office for Public Health launched an HTA program intending to reassess the benefits already reimbursed by compulsory health insurance. The following ongoing re-evaluations are in progress: multigene expression tests in breast cancer, cardiac catheterization for coronary artery disease, invasive procedures for coronary artery disease, removal of osteosynthesis materials, etc.
Read more
14
Dec 2021
In early December 2021, NHS Accelerated Access Collaborative announced seven technologies that will be covered by the MedTech Funding Mandate (MTFM) in 2022/23: four for benign prostatic hyperplasia treatment (UroLift, GreenLight XPS, Rezum, and PLASMA system), and three for improving the patient experience during procedures (XprESS multi-sinus dilation system, Thopaz+, and Spectra Optia). Four technologies included in 2021/22 (placental growth factor-based testing, SecurAcath, HeartFlow, and gammaCore) will continue to be supported.
Read more
13
Dec 2021
In late November – early December 2021, the application period for 2023 ICD-10-GM (German modification of ICD-10 diagnosis codes), OPS (procedure codes), and DRG changes was opened by the Federal Institute for Drugs and Medical Devices (BfArM), and the Institute for Hospital Remuneration Systems (INeK), respectively.
Read more
10
Dec 2021
The Dutch Organization for Health Research and Development (ZonMw), in collaboration with the National Health Care Institute (ZIN), initiated the new HTA Methodology Program for 2021-2024. On November 4, 2021, the ZonMw published the gap analysis of the needs of important stakeholders regarding HTA and formulated recommendations that can provide guidance for the 2021-2024 HTA Methodology Program.
Read more